Introduction: Clinical response to deep brain stimulation (DBS) strongly depends on the appropriate placement of the electrode in the targeted structure. Postoperative MRI is recognized as the gold standard to verify the DBS-electrode position in relation to the intended anatomical target. However, intraoperative computed tomography (iCT) might be a feasible alternative to MRI.
INTRODUCTION
Deep brain stimulation (DBS) is a well-recognized and effective neurosurgical treatment for various movement disorders. The clinical effect of DBS largely depends on the appropriate placement of the electrode in the targeted structure (1) . Therefore, a correct assessment of the electrode position with imaging techniques during or directly after the surgical procedure is crucial, since it can timely indicate a necessary repositioning of the electrode.
Magnetic resonance imaging (MRI) is considered to be the gold standard to assess the electrode position after DBS implantation (2) (3) (4) (5) (6) (7) (8) (9) . MRI offers detailed visualization of relevant brain structures. However, image distortion caused by local magnetic field inhomogeneity may cause a nonconcentric artifact, usually larger than the electrode itself, which could possibly have a negative impact on the suitability of MRI for electrode position assessment (8, 10, 11) .
Intraoperative computed tomography (iCT) offers a high spatial resolution and a good delineation of the DBS electrode, providing a precise localization of the electrode (12) . CT is significantly cheaper (13) and less time consuming than MRI. Furthermore, while iCT is readily available in most hospital settings, access to an intraoperative MRI is often limited.
A number of studies have been conducted regarding the most suitable imaging modality for assessing accuracy in DBS (10, (14) (15) (16) . However, these studies had several methodological limitations, such as nonconsecutive inclusions (10, 16) , only a retrospective character (10, 15, 16) , uncertainty about the duration between CT and MRI scan (10, 16) and the lack of sample size calculations (10, (14) (15) (16) .
This study was designed to compare iCT (fused with preoperative MRI (15, (17) (18) (19) ) with early postoperative MRI for electrode position verification in DBS surgery.
MATERIALS AND METHODS

Study Population and DBS Targets
We prospectively studied a single-institution series of 29 consecutive patients (mean age 58 AE 13.6 years, range: 16-76) undergoing bilateral DBS placement (58 electrodes) between November 2016 and April 2018. Thirty-eight electrodes were implanted in the subthalamic nucleus (STN), 14 in the internal globus pallidus (GPi), 4 in the zona incerta (ZI), and 2 in the thalamic ventral intermediate nucleus (VIM).
Imaging and Targeting
DBS targeting was based on preoperative 3 T MRI (Philips Intera, Eindhoven, the Netherlands), using the planning software iPlan 3.6 (Brainlab, Feldkirchen, Germany). Targeting was independently performed by two neurosurgeons. Preoperative stereotactic CT images (Sensation 64, Siemens, Erlangen, Germany) using the Leksell G frame (Elekta, Stockholm, Sweden) were transferred to the iPlan software and subsequently fused with the preoperative 3 T MRI to register the planned target in the stereotactic coordinate system. During the surgical procedure, immediately after bilateral lead placement, patients were brought to the Medical Imaging Unit, in which iCT images were obtained on a diagnostic CT suite (Sensation 64). A deviation from the intended target was manually calculated based on the iCT scan, using the iPlan probe view tool. If the lead was positioned <2 mm from the intended target, lead positioning was accepted. On the contrary, if a deviation of ≥2 mm off-target was determined, lead repositioning was performed immediately. Only one iCT verification was performed per patient. Afterwards, the internal pulse generator was implanted under general anesthesia. Within 24 to 72 hours after surgery, patients underwent 1.5 T-MRI (Aera, Siemens, Erlangen, Germany). Refer to Table 1 for imaging protocol specification.
The iCT and postoperative MRI datasets were fused to the preoperative stereotactic CT. The fusion of images by iPlan 3.6 runs automatically, using a mutual information algorithm for dataset correlation.
Lead Visualization and Localization iPlan 3.6 was used to localize the leads. To improve visualization, a new trajectory was planned along the center of the lead artifact with a diameter of 1.2 mm, corresponding to the diameter of the actual lead (1.27 mm).
Lead artifacts appear differently on iCT and MRI (Fig. 1 ). An ellipsoid shaped artifact was seen on MRI, while a clear, welldelineated hyperdense artifact was seen on iCT. On iCT, a specific window level setting (Houndsfield Unit (HU) level: 1100 HU, width: 50 HU) was chosen to maximize contrast between lead and surrounding tissue, improving visualization. The lead position was determined as the imaginary center of the artifact on both modalities (Fig. 2) . From the iCT and MRI datasets, the stereotactic coordinates of the lead tip were obtained, taking the most caudal part of the lead artifact as the lead tip position.
To study interobserver reliability, the plotting of the electrode trajectories was repeated by a neuroradiologist for all patients.
Direct Comparison Between Modalities: Euclidean Distance, Radial Error, and Depth
Lead tip coordinates were compared between both imaging modalities. The Euclidean distance between lead tip positions as determined on iCT and MRI was calculated for all electrodes.
Besides the Euclidean distance, radial error and depth were assessed. Radial error is defined as the 2D distance in X and Y plane. For these assessments, the iCT lead was plotted into the postoperative MRI. Via the iPlan probe view tool, radial distance and depth were determined between the centers of both lead tips.
Indirect Comparison Between Modalities: Accuracy Relative to Target
Furthermore, the difference between both modalities and the intended target was determined. Targets were assessed according to the intended nucleus. The target is placed in the −1/+2 contact spacing of the DBS lead when the target is in the STN, VIM, or ZI, while in GPi stimulation, the intention is to insert the lead tip at target.
In the STN, VIM, ZI leads (44 leads), coordinates of the −1/+2 contact spacing of the DBS lead were calculated using vector www.neuromodulationjournal.com geometry. The Euclidean distance between these coordinates and the intended target coordinates were calculated, using the aforementioned formula.
In the GPi leads (14 leads), the Euclidean distance between the lead tip coordinates and the intended target coordinates were calculated.
Statistical Analysis
The primary hypothesis was that iCT would be noninferior to postoperative MRI for the verification of the DBS lead position. We determined a noninferiority margin of 2 mm. It has been described in literature (20) (21) (22) that the weighted mean distance between lead tips on CT and MRI is 1.50 AE 0.50 mm. Accordingly, we estimated a difference of 0.50 mm or more to be clinically relevant for the accuracy estimation. To calculate our sample size, we used a Cohen's d (mean difference/standard deviation, d) of 1. Based on a power (1 − β) of 0.95 and an alpha significance level (α) of 0.025, we estimated that 16 electrode distances were needed for our statistical analysis.
Calculations were performed according to the formula (23):
In which f is the function of α and β, σ is the standard deviation, and d is the noninferiority limit.
Thus, 29 participants implanted with 58 electrodes had sufficient power determine the possible noninferiority of iCT to MRI.
Euclidean distances resulted from the direct comparison of iCT and MRI leads, were compared with the mean distance previously reported in literature using a one sample right-tailed t-test. Confidence intervals (CIs) were calculated to determine whether the upper limit of the CI exceeded the noninferiority margin.
For the indirect comparison between modalities, a linear Deming regression was performed between the error from target to lead in Euclidean distance, estimated both using MRI and CT. The variances were assumed to be similar between both modalities (lambda = 1) and the level of significance alpha was determined at 0.05. The correlation between both techniques was estimated using Pearson's r.
The statistical analysis was performed using R version 3.5.1 and the statistical package mcr. Descriptive statistics are given with mean and standard deviation. Intraclass correlation (ICC) with 95% CI were obtained for two raters for interobserver reliability.
According to Dutch legislation, the local research ethical board stated that the study was not submitted to the Medical Research Involving Human Subjects Act (WMO).
RESULTS
Direct Comparison Between
In our cohort, one lead position was revised after initial implantation because the lead was placed 2 mm too superficial as determined on iCT. After placing the lead 2 mm more caudal, an additional iCT was not acquired. Therefore, this lead was excluded and analysis was performed in 57 leads. The average Euclidean distance between lead tips was 0.98 AE 0.49 mm; 0.97 AE 0.47 mm for the left-sided electrode and 1.00 AE 0.53 mm for the rightsided electrode ( Table 2 ). The calculated mean Euclidean distances were not significantly higher than the reported weighted mean (t 56 = −7.9335, p = 1). The upper CI (0.851-1.112) did not exceed the noninferiority margin established.
The average radial error between lead tips was 0.74 AE 0.48 mm, whereas the average depth error was determined to be 0.53 AE 0.40 mm.
Indirect comparison between modalities: accuracy relative to target
On iCT, the average Euclidean distance between the DBS lead and the intended target was 1.71 AE 0.61 mm; 1.98 AE 0.61 mm for the left-sided electrode and 1.40 AE 0.45 mm for the right-sided electrode.
On MRI, the average Euclidean distance between the DBS lead and the intended target was 1.94 AE 0.74 mm; 2.19 AE 0.61 mm for the leftsided electrode and 1.70 AE 0.79 mm for the right-sided electrode.
The linear Deming regression indicated a good agreement between both imaging modalities (intercept 0.066, CI −0.3607 to 0.5310, slope 0.08362, CI 0.6047 to 1.0326). The CI of the intercept contains 0, which indicates no significant accuracy difference between CT and MRI, while the CI of the slope contains 1, which indicates no significant difference in the precision of both imaging techniques. Pearson's r was 0.798, showing a strong correlation between both MRI and CT (Fig. 3) .
Intraclass Correlations
The lead tip two-rater interobserver ICC showed an almost perfect agreement for both iCT and MRI measurements, 0.999 (95% CI; range: 0.699-1.000) and 0.995 (95% CI; range: 0.940-0.998), respectively.
DISCUSSION
Ideally, proper visualization of the DBS lead and the nucleus borders of the target would either ensure correct lead position or shed light upon the need for revision. Unfortunately, the current imaging techniques have not reached the stage in which both DBS lead and nucleus borders can be clearly visualized. MRI offers detailed visualization of relevant brain structures, but also induces an artifact that overestimates the actual electrode. Besides, DBS systems are not always compatible with MRI and occurrence of adverse events have been described in DBS implanted patients after MRI (24) . Also, the specific absorption rate limits implemented in MRI safety protocols as a result of these concerns can limit the quality of the images (depending on sequence), resulting in suboptimal images for lead verification. In addition, access to an intraoperative MRI suite is limited in most hospitals. All the more reason for the entry of an alternative imaging modality in DBS surgery. Our study shows that iCT is noninferior to MRI for the verification of lead position in DBS surgery. The average Euclidean distance between lead tip position determined on iCT and MRI was 0.98 mm AE 0.49 mm, which is lower than the noninferiority margin for significant clinical relevance.
The differences found in this study are smaller than those found in other studies on lead localization in DBS. Shahlaie et al. (20) found differences of 1.65 AE 0.19 mm between lead tips on iCT and postoperative MRI. Based on the conclusions of previous publications (16, 18, 20) and the results obtained in this article, the authors agree that iCT could replace postoperative MRI in assessing DBS leads. Lee et al. (10) directly fused postoperative CT and postoperative MRI and subsequently compared the lead centers at five different levels. The lead centers showed differences of 1.08 mm to 1.40 mm. Thani et al. (22) performed intraoperative MRI with a surrogate marker (carbothane stylette, in which the lead was placed later) and fused this dataset with postoperative CT (with DBS electrodes) to calculate the discrepancy between the location of the active contact of the two images. The discrepancy found was 1.60 AE 0.20 mm. Carlson et al. (21) reported a distance of 1.43 AE 0.66 mm comparing postoperative MRI (1-2 weeks) and postoperative CT (12 hours).
Besides studying the difference of the lead tip position on iCT and MRI, the difference between the lead and the intended target was assessed on each modality, because this information is very important for the intraoperative decision to revise the lead or not. Larger Euclidean distances were found between target and DBS lead on MRI, compared to iCT (1.94 AE 0.74 mm vs. 1.71 AE 0.61 mm). This difference between modalities is most likely caused by the difficulty both lead tip assessors experienced identifying the lead tip on MRI. The often unclear black artifact was not welldelineated and showed a gradual beginning at the lead tip, making it difficult to accurately mark the lead tip. Difficulty visualizing the lead tip on MRI imaging has been described before (16, 18) .
Assessing Lead Position Based on Artifact Visualization
On both CT and MRI the electrode induces an artifact that exceeds the actual electrode size. To accurately assess lead positioning on imaging, it is important to exactly know the electrode position in relation to the artifact. On MRI, DBS leads are depicted as ellipse-shaped low signal artifacts, in which each contact point individually induces a symmetrical artifact extending approximately 1.4 mm over the proximal and distal ends of the contact and 1.16 mm over the lateral limit of the contact (11) . This suggests that both the artifact and the relative contact have the same center (8, 11) . Pollo et al. thus identified 1.4 mm to be the distance on MRI between the distal limit of the artifact and the distal limit of the first contact (contact 0). On CT, lead artifacts appear as a clear, hyperdense signal in the darkened (after windowing) intracranial space. Because of the high spatial fidelity of CT, the artifact is likely to be concentrically formed around the lead (25). Hemm et al. conducted a study based on lead artifacts on CT images and found distances of 1.1 mm and 1.2 mm between the beginning of the artifact and the distal limit of contact 0, in their in vivo and in vitro study, respectively (12) . In our study, the above cited distances were taken into account when calculating the exact position of the −1/+2 contact spacing for assessing the lead position relative to target.
Limitations
The position of the lead tip and the lead position relative to the target was compared between modalities, taken into account the imaging specific characteristics of the different lead artifacts. However, since the distance from lead tip to contact 0 varies between MRI and CT (1.4 mm vs. 1.2 mm), contact 0 might be more suitable than the lead tip to compare modalities. Nonetheless, the lead tip has been extensively used to study accuracy in the past (26) (27) (28) (29) and a difference of 0.2 mm between modalities is very small. Fusion error could have played a role in the accuracy of lead measurements. When fusion between imaging sets was being performed, fusion was always visually verified by checking ventricular and sulcal shape. In none of the cases manual fusion adjustment was necessary.
Another limitation in our study might be the difference in time between the iCT and the postoperative MRI (24-72 hours) . Ideally, the postoperative MRI should be performed directly after the iCT to minimize any effects related to brain shift, but this was not possible because of logistic reasons. Therefore, brain shift could have led to a less reliable comparison between both imaging modalities.
Future Perspectives
The results show that iCT is noninferior to postoperative MRI for lead localization in DBS surgery. Our institution may therefore have the possibility of proceeding towards an asleep DBS procedure using iCT, since iCT proves to measure up to the gold standard, MRI. Good results have been published by recent studies regarding asleep DBS surgery (30) (31) (32) (33) (34) (35) (36) (37) (38) . Asleep DBS is proven to be safe and without differences in adverse events compared to awake DBS (33) . The asleep procedure could possibly be even more effective (35) and may be cheaper (39) than operating in an awake situation. Risk of surgical complications such as hemorrhages or infections are also significantly less frequent in asleep DBS (32, 37) .
In the current study, we have proven iCT to be noninferior to postoperative MRI, whereby our surgical group can advance to performing asleep surgery in our patients using iCT. The lack of MRI availability does not hinder the possibility to perform asleep DBS surgery.
CONCLUSION
In this prospective study iCT was found to be noninferior to postoperative MRI for the verification of the lead position in DBS surgery. There were no relevant differences between the lead position on iCT and postoperative MRI. In conclusion, both modalities have their pros and cons, but either one is suitable for lead position verification in DBS surgery.
Authorship Statements
Ms. Kremer, Dr. Oterdoom, Mr. van Hulzen, and Dr. van Dijk designed and conducted the study, including data collection and data analysis. Dr. PJ van Laar is also responsible for data collection. Ms. Kremer prepared the manuscript draft with important intellectual input from Dr. Oterdoom, Dr. Piña-Fuentes, Dr. T van Laar, Dr. Drost, Mr. van Hulzen, and Dr. van Dijk. All authors approved the final manuscript. Statistical support in analyzing the data with input from Ms. Kremer and Dr. Piña-Fuentes. Ms. Kremer, Dr. Piña-Fuentes, and Mr. van Hulzen had complete access to the study data. 
